Langerhans cells: Central players in the pathophysiology of atopic dermatitis

Author:

Pan Yi12ORCID,Hochgerner Mathias3ORCID,Cichoń Małgorzata Anna4ORCID,Benezeder Theresa2ORCID,Bieber Thomas156ORCID,Wolf Peter2ORCID

Affiliation:

1. Department of Dermatology and Allergy University Hospital of Bonn Bonn Germany

2. Department of Dermatology and Venerology Medical University of Graz Graz Austria

3. Greater Bay Area Institute of Precision Medicine (Guangzhou), School of Life Sciences, Fudan University Shanghai China

4. Institute of Science and Technology Austria (IST Austria) Klosterneuburg Austria

5. CK‐CARE, Medicine Campus Davos Switzerland

6. Department of Dermatology University Hospital of Zürich Zürich Switzerland

Abstract

AbstractAtopic dermatitis (AD) is the most common chronic inflammatory skin disease worldwide. AD is a highly complex disease with different subtypes. Many elements of AD pathophysiology have been described, but if/how they interact with each other or which mechanisms are important in which patients is still unclear. Langerhans cells (LCs) are antigen‐presenting cells (APCs) in the epidermis. Depending on the context, they can act either pro‐ or anti‐inflammatory. Many different studies have investigated LCs in the context of AD and found them to be connected to all major mechanisms of AD pathophysiology. As APCs, LCs recruit other immune cells and shape the immune response, especially adaptive immunity via polarization of T cells. As sentinel cells, LCs are primary sensors of the skin microbiome and are important for the decision of immunity versus tolerance. LCs are also involved with the integrity of the skin barrier by influencing tight junctions. Finally, LCs are important cells in the neuro‐immune crosstalk in the skin. In this review, we provide an overview about the many different roles of LCs in AD. Understanding LCs might bring us closer to a more complete understanding of this highly complex disease. Potentially, modulating LCs might offer new options for targeted therapies for AD patients.

Funder

China Scholarship Council

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3